Education
About Us
Working with TipRanks
Follow Us
Astria Therapeutics (ATXS)
NASDAQ:ATXS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -111.56M | $ -83.03M | $ -53.50M | $ -194.98M | $ -37.44M |
| EBITDA | $ -111.56M | $ -83.03M | $ -53.50M | $ -30.36M | $ -37.41M |
| Net Income | $ -94.26M | $ -72.89M | $ -51.83M | $ -194.91M | $ -37.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 328.13M | $ 246.53M | $ 226.44M | $ 125.51M | $ 44.93M |
| Total Assets | $ 342.36M | $ 254.67M | $ 230.63M | $ 127.51M | $ 47.46M |
| Total Debt | $ 5.35M | $ 329.00K | $ 939.00K | $ 365.00K | $ 1.05M |
| Net Debt | $ -54.47M | $ -175.20M | $ -19.59M | $ -86.14M | $ -23.88M |
| Total Liabilities | $ 23.10M | $ 11.55M | $ 9.42M | $ 5.20M | $ 6.79M |
| Stockholders' Equity | $ 319.26M | $ 243.12M | $ 221.22M | $ 122.31M | $ 40.67M |
| Cash Flow | |||||
| Free Cash Flow | $ -81.54M | $ -68.47M | $ -43.62M | $ -30.17M | $ -32.52M |
| Operating Cash Flow | $ -81.21M | $ -68.44M | $ -43.53M | $ -30.15M | $ -32.48M |
| Investing Cash Flow | $ -191.86M | $ 135.05M | $ -167.13M | $ -12.55M | $ 6.30M |
| Financing Cash Flow | $ 157.20M | $ 88.40M | $ 144.72M | $ 104.28M | $ 40.86M |